[go: up one dir, main page]

FI950459L - Argatrobaanin konsentroituja vesiliuoksia - Google Patents

Argatrobaanin konsentroituja vesiliuoksia Download PDF

Info

Publication number
FI950459L
FI950459L FI950459A FI950459A FI950459L FI 950459 L FI950459 L FI 950459L FI 950459 A FI950459 A FI 950459A FI 950459 A FI950459 A FI 950459A FI 950459 L FI950459 L FI 950459L
Authority
FI
Finland
Prior art keywords
argatroban
aqueous solutions
concentrated aqueous
concentrated
solutions
Prior art date
Application number
FI950459A
Other languages
English (en)
Swedish (sv)
Other versions
FI950459A0 (fi
Inventor
Frederic Andre
Veronique Avril
Jean Montel
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI950459A0 publication Critical patent/FI950459A0/fi
Publication of FI950459L publication Critical patent/FI950459L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
FI950459A 1994-02-03 1995-02-02 Argatrobaanin konsentroituja vesiliuoksia FI950459L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401195A FR2715566B1 (fr) 1994-02-03 1994-02-03 Solutions aqueuses concentrées d'argatroban.

Publications (2)

Publication Number Publication Date
FI950459A0 FI950459A0 (fi) 1995-02-02
FI950459L true FI950459L (fi) 1995-08-04

Family

ID=9459714

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950459A FI950459L (fi) 1994-02-03 1995-02-02 Argatrobaanin konsentroituja vesiliuoksia

Country Status (25)

Country Link
US (1) US5679690A (fi)
EP (1) EP0669131B1 (fi)
JP (1) JP3027103B2 (fi)
KR (1) KR100257692B1 (fi)
CN (1) CN1054743C (fi)
AT (1) ATE179327T1 (fi)
AU (1) AU687133B2 (fi)
CA (1) CA2141704C (fi)
CZ (1) CZ284611B6 (fi)
DE (1) DE69509279T2 (fi)
DK (1) DK0669131T3 (fi)
ES (1) ES2132547T3 (fi)
FI (1) FI950459L (fi)
FR (1) FR2715566B1 (fi)
GR (1) GR3030149T3 (fi)
HK (1) HK1013623A1 (fi)
HU (1) HU218220B (fi)
IL (1) IL112527A (fi)
NO (1) NO307324B1 (fi)
NZ (1) NZ270445A (fi)
PL (1) PL178586B1 (fi)
RU (1) RU2136282C1 (fi)
SK (1) SK12795A3 (fi)
TW (1) TW436295B (fi)
ZA (1) ZA95837B (fi)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5786153A (en) * 1996-09-12 1998-07-28 Chiron Diagnostics Corporation Prevention of probe coating on automated analyzers using a non-denaturing surfactant
CA2291735A1 (en) * 1997-05-27 1998-12-03 Takahiro Ogawa Israpafant-containing water-base preparations
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
FR2793412B1 (fr) * 1999-05-11 2001-07-27 Synthelabo Formulations galeniques d'argatroban pour administration sous-cutanee
KR100399373B1 (ko) * 2000-12-20 2003-09-26 주식회사 아이센스 콜란산 고리를 포함하는 디글라이콜릭 디아마이드 유도체,그의 제조방법 및 용도
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US7041468B2 (en) 2001-04-02 2006-05-09 Therasense, Inc. Blood glucose tracking apparatus and methods
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
AU2003303597A1 (en) 2002-12-31 2004-07-29 Therasense, Inc. Continuous glucose monitoring system and methods of use
JP3781308B2 (ja) * 2003-03-20 2006-05-31 三菱ウェルファーマ株式会社 アルギニンアミド類を含有する医薬製剤
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
WO2005089103A2 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
WO2007027565A2 (en) * 2005-09-01 2007-03-08 Baxter International Inc. Argatroban formulation comprising an acid as solubilizer
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
WO2007143225A2 (en) 2006-06-07 2007-12-13 Abbott Diabetes Care, Inc. Analyte monitoring system and method
WO2008027958A2 (en) * 2006-08-31 2008-03-06 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US7589106B2 (en) * 2006-09-27 2009-09-15 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US7687516B2 (en) * 2006-09-27 2010-03-30 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US20100076019A1 (en) * 2006-10-11 2010-03-25 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8703204B2 (en) 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
US8309129B2 (en) 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8974827B2 (en) 2007-06-04 2015-03-10 Bend Research, Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US9545384B2 (en) 2007-06-04 2017-01-17 Bend Research, Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US7915290B2 (en) 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
US20090221637A1 (en) * 2008-02-29 2009-09-03 Baxter International Inc. Solid-state salt argatroban formulations and methods for producing and using the same
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
EP2473099A4 (en) 2009-08-31 2015-01-14 Abbott Diabetes Care Inc ANALYTICAL SUBSTANCE MONITORING SYSTEM AND METHODS OF MANAGING ENERGY AND NOISE
WO2011026147A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte signal processing device and methods
WO2011041469A1 (en) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
CN102366410B (zh) * 2011-09-14 2013-05-29 海南灵康制药有限公司 一种阿加曲班脂质体注射剂
EP3677182B1 (en) 2011-11-07 2022-05-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
WO2015006679A2 (en) 2013-07-11 2015-01-15 Aqua Turf International, Inc. Air filtration mask with opening front cover
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
CN114025746B (zh) * 2019-05-10 2023-08-25 福多兹制药公司 抗血栓形成剂的可注射聚合物纳米颗粒组合物及其方法
CN110478471B (zh) * 2019-09-17 2020-04-10 鲁南制药集团股份有限公司 一种阿加曲班注射液及其制备方法
WO2022003954A1 (ja) 2020-07-03 2022-01-06 東芝三菱電機産業システム株式会社 無停電電源システム
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
CN113855635A (zh) * 2021-10-20 2021-12-31 陇南市第一人民医院 一种阿加曲班注射液脂质体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
JPS6431727A (en) * 1987-07-28 1989-02-02 Mitsubishi Chem Ind Dissolution of argininamide and drug composition containing argininamides
JPH02129123A (ja) * 1988-11-07 1990-05-17 Mitsubishi Kasei Corp 抗血液凝固剤
TW225477B (fi) * 1992-03-18 1994-06-21 Mitsubishi Kakoki Kk
EP0566897A3 (en) * 1992-04-07 1994-07-06 Hoechst Ag The complete gene (cefg) encoding the acetyl-coa: deacetylcephalosporin c acetyltransferase of cephalosporium acremonium, its isolation and use

Also Published As

Publication number Publication date
NO950377L (no) 1995-08-04
CZ27195A3 (en) 1995-09-13
NZ270445A (en) 1995-07-26
DE69509279T2 (de) 1999-11-25
EP0669131A1 (fr) 1995-08-30
FI950459A0 (fi) 1995-02-02
TW436295B (en) 2001-05-28
DE69509279D1 (de) 1999-06-02
NO307324B1 (no) 2000-03-20
FR2715566A1 (fr) 1995-08-04
CN1109754A (zh) 1995-10-11
PL307041A1 (en) 1995-08-07
ATE179327T1 (de) 1999-05-15
CN1054743C (zh) 2000-07-26
HU218220B (hu) 2000-06-28
HUT71524A (en) 1995-12-28
RU2136282C1 (ru) 1999-09-10
JPH07277980A (ja) 1995-10-24
PL178586B1 (pl) 2000-05-31
FR2715566B1 (fr) 1996-03-08
AU1154395A (en) 1995-08-10
HK1013623A1 (en) 1999-09-03
IL112527A (en) 1999-04-11
CA2141704C (fr) 2001-07-03
RU95101387A (ru) 1997-02-27
AU687133B2 (en) 1998-02-19
SK12795A3 (en) 1995-08-09
ES2132547T3 (es) 1999-08-16
EP0669131B1 (fr) 1999-04-28
GR3030149T3 (en) 1999-08-31
IL112527A0 (en) 1995-05-26
JP3027103B2 (ja) 2000-03-27
NO950377D0 (no) 1995-02-02
KR100257692B1 (ko) 2000-08-01
ZA95837B (en) 1996-03-29
DK0669131T3 (da) 1999-11-01
KR950031042A (ko) 1995-12-18
CZ284611B6 (cs) 1999-01-13
CA2141704A1 (fr) 1995-08-04
US5679690A (en) 1997-10-21

Similar Documents

Publication Publication Date Title
FI950459L (fi) Argatrobaanin konsentroituja vesiliuoksia
EE9700009A (et) Risperidooni vesilahuselised ravimvormid
FI953310L (fi) Vesipitoisten liuosten desinfiointi
DE69823016D1 (de) Wässrige lösungen von salicylsaure derivaten
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
FI955305L (fi) Tekijä VIII:n vähähappinen vesiliuos
BR9601276A (pt) Solução de interferona aquosa
FI955353L (fi) Vesipitoinen hopeakoostumus
DE69614516D1 (de) Nanofiltration von konzentrierten wässrigen salzlösungen
MX9200450A (es) Suspensiones acuosas de acidos peroxicarboxilicos.
EE03949B1 (et) Ravimivesilahused propellentgaasivabade aerosoolide tootmiseks
FI951245L (fi) Liuosten muodostaminen
DE69122646D1 (de) Konzentrierte wässrige Tensidlösung
BR9404552A (pt) Composição aquosa
NO931495D0 (no) Vandige saltopploesninger
DE69504151D1 (de) Wässrige Emulsion
DE69521091D1 (de) Wässriger Zweipack-Klebstoff
ATA236791A (de) Wässerige piroxicamlösungen
MX163810B (es) Solucion acuosa concentrada de glutaraldehido y 1-2-bencicotiazolin-3-ona
DE69605444D1 (de) Entwässerung von wässrigen suspensionen
DE69500881D1 (de) Oxidation von uranhexafluorid
FI945092L (fi) Epoksimeripihkahappojohdannaiset
FI934687L (fi) Vattenhaltiga komposition
DE59908817D1 (de) Wässrige zubereitungen
FI963648L (fi) Epäorgaanisten aineiden vesisuspensiot